[1]喻荷淋,吴 艳,蒋 莉,等.妊娠期糖尿病患者脐血FGF19水平与胰岛素抵抗及新生儿出生体重的关系[J].医学信息,2021,34(06):90-92.[doi:10.3969/j.issn.1006-1959.2021.06.023]
　YU He-lin,WU Yan,JIANG Li,et al.The Relationship between Cord Blood FGF19 Level and Insulin Resistance and Birth Weight in Patients with Gestational Diabetes[J].Medical Information,2021,34(06):90-92.[doi:10.3969/j.issn.1006-1959.2021.06.023]
点击复制

妊娠期糖尿病患者脐血FGF19水平与胰岛素抵抗及新生儿出生体重的关系()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年06期
页码:
90-92
栏目:
论著
出版日期:
2021-03-15

文章信息/Info

Title:
The Relationship between Cord Blood FGF19 Level and Insulin Resistance and Birth Weight in Patients with Gestational Diabetes
文章编号:
1006-1959（2021）06-0090-03
作者:
喻荷淋; 吴 艳; 蒋 莉; 等
（四川省遂宁市中心医院内分泌代谢病科，四川 遂宁 629000）
Author(s):
YU He-lin; WU Yan; JIANG Li; et al.
(Department of Endocrinology and Metabolism,Suining Central Hospital,Suining 629000,Sichuan,China)
关键词:
妊娠期糖尿病; 新生儿体重; 脐血FGF19; 胰岛素抵抗
Keywords:
estational diabetes; Newborn weight; Cord blood FGF19; Insulin resistance
分类号:
R714.256
DOI:
10.3969/j.issn.1006-1959.2021.06.023
文献标志码:
A
摘要:
目的 探讨妊娠期糖尿病（GDM）患者脐血成纤维细胞因子19（FGF19）浓度的变化与胎儿胰岛素抵抗（IR）、出生时体重的相关性。方法 选择2017年2月~2018年11月于遂宁市中心医院住院分娩的GDM患者44例为病例组，正常妊娠期妇女44例为对照组，分别测定两组脐血FGF19、血糖胰岛素水平，计算胰岛素抵抗指数（HOMA-IR），测量新生儿的身长、体重，并分析脐血FGF19与以上指标的相关性。结果 病例组脐血FGF19水平低于对照组，胰岛素、HOMA-IR、新生儿体重高于对照组（P＜0.05），病例组脐血FGF19水平与血糖、胰岛素、HOMA-IR及新生儿体重呈负相关（r=-0.583、-0.892、-0.804、-0.513，P＜0.05）。胰岛素、HOMA-IR是FGF19降低的独立危险因素（P＜0.05）。结论 GDM患者脐血中FGF19水平明显降低，与胰岛素抵抗、新生儿体重相关。脐血FGF19的变化可作为预测新生儿出生时体重及健康的指标。
Abstract:
Objective To investigate the relationship between the change of cord blood fibroblast factor 19 (FGF19) concentration and fetal insulin resistance (IR) and birth weight in patients with gestational diabetes (GDM).Methods 44 cases of GDM patients who were hospitalized in Suining Central Hospital from February 2017 to November 2018 were selected as the case group, and 44 cases of normal pregnancy women were selected as the control group.The two groups of cord blood FGF19, blood glucose insulin levels were measured respectively, the insulin resistance index (HOMA-IR) was calculated, the length and weight of the newborn were measured, and the correlation between cord blood FGF19 and the above indicators was analyzed.Results The cord blood FGF19 level of the case group was lower than that of the control group, and the insulin, HOMA-IR, and neonatal weight were higher than that of the control group (P＜0.05).The cord blood FGF19 level in the case group was negatively correlated with blood glucose, insulin, HOMA-IR and newborn weight (r=-0.583, -0.892, -0.804, -0.513,P＜0.05).Insulin and HOMA-IR were independent risk factors for FGF19 reduction (P＜0.05).Conclusion The level of FGF19 in the cord blood of patients with GDM is significantly reduced, which is related to insulin resistance and neonatal weight. The change of cord blood FGF19 can be used as an index to predict the birth weight and health of newborns.

参考文献/References:

[1]Koivusalo SB,Rono K,Klemetti MM,et al.Gestational diabetes mellitus can be prevented by lifestyle intervention:the finnish gestational diabetes prevention study（RADIEL）:a randomized controlled Trial[J].Diabetes Care,2016,39(1):24-30. [2]Zhu WW,Fan L,Yang HX,et al.Fasting Plasma Glucose at 24-28 Weeks to Screen for Gestational Diabetes Mellitus:New evidence from China[J].Diabetes Care,2013,36(7):2038-2040. [3]Degirolamo C,Sabba C,Moschetta A.Therapeutic potential of the endocrine fibroblast growth factors FGF19,FGF21,and FGF23[J].Nat Rev Drug Discov,2016,15(1):51-69. [4]Gallego-Escurdeo JM,Gomez-Ambrosi J,Catalan V,et al.Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patientes[J].Int J Obes,2015,39(1):121-129. [5]Roesch SL,Styer AM,Wood GC,et al.Perturbations of fibroblast growth factors 19 and 21 in type 2 diabetes[J].PLoS One,2015,10(2):e0116928. [6]Wang D,Zhu W,Li J,et al.Serum concentrations of fibroblast growth factors 19 and 21 in women with gestational diabetes mellitus:association with insulin resistance,adiponectin,and polycystic ovary syndrome history[J].PLoS One,2013,8(11):e81190. [7]徐千越,葛智娟,胡君,等.妊娠期糖尿病患者孕期体重增加不同控制标准与妊娠不良结局发生的相关性研究[J].中国糖尿病杂志,2019,27(9):641-646. [8]Mraz M,Lacinova Z,Kavalkova P,et al.Serum concentrations of fibroblast growth factor 19 in patients with obesity and type 2 diabetes mellitus:the influence of acute hyperinsulinemia,very-low calorie diet and PPAR-α agonist treatment[J].Physiol Res,2011,60(4):627-636. [9]Fu T,Chui SE,Kim DH,et al.Aberrantly elevated microRNA-34α in obesity attenuates hepatic responses to FGF19 by targeting a membrane coreceptor beta-Klotho[J].Proc Natl Acad Sci USA,2012,109(40):16137-16142. [10]Zhou M,Marc Learned R,Rossi SJ,et al.Engineered fibroblast growth factor 19 reduces liver injury and resolves sclerosing cholangitis in Mdr2-deficient [J].Hepatology,2016,63(3):914-929. [11]Lee BC,Lee J.Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance[J].Biochimica et Biophysica Acts(BBA)-Molecular Basis of Disease,2014,1842(3):446-462. [12]Perry RJ,Lee S,Ma L,et al.FGFI and FGFl9 reverse diabetes by suppression of the hypothalamic-pituitary-adrenalaxis[J].Nat Commun,2015,6(4):6980. [13]Wu X,Ge H,Baribault H,et al.Dual actions of fibrolast growth factor 19 on lipid metabolism[J].J Lipid Res,2013,54(2):325-332.

相似文献/References:

[1]范新婷.层级护理在妊娠期糖尿病孕妇剖宫产中的应用研究[J].医学信息,2018,31(02):168.[doi:10.3969/j.issn.1006-1959.2018.02.065]
　FAN Xin-ting.Study on the Application of Hierarchical Nursing in Cesarean Section of Pregnant Women with Gestational Diabetes Mellitus[J].Medical Information,2018,31(06):168.[doi:10.3969/j.issn.1006-1959.2018.02.065]
[2]孟召然,李 玲,范建辉.妊娠期糖尿病相关危险因素分析[J].医学信息,2018,31(04):81.[doi:10.3969/j.issn.1006-1959.2018.04.026]
　MENG Zhao-ran,LI Ling,FAN Jian-hui.Analysis of Risk Factors Related to Gestational Diabetes Mellitus[J].Medical Information,2018,31(06):81.[doi:10.3969/j.issn.1006-1959.2018.04.026]
[3]王 荣.诺和锐特充治疗妊娠期糖尿病的临床效果观察[J].医学信息,2018,31(08):186.[doi:10.3969/j.issn.1006-1959.2018.08.069]
　WANG Rong.Clinical Observation on the Treatment of Gestational Diabetes Mellitus with Novoterol[J].Medical Information,2018,31(06):186.[doi:10.3969/j.issn.1006-1959.2018.08.069]
[4]李雪莲.妊娠合并糖尿病对分娩结局的影响观察[J].医学信息,2018,31(10):114.[doi:10.3969/j.issn.1006-1959.2018.10.036]
　LI Xue-lian.Effect of Pregnancy Complicated with Diabetes on Delivery Outcome[J].Medical Information,2018,31(06):114.[doi:10.3969/j.issn.1006-1959.2018.10.036]
[5]屈利洁.围生期综合护理措施及营养干预对妊娠期糖尿病患者的价值[J].医学信息,2018,31(15):171.[doi:10.3969/j.issn.1006-1959.2018.15.057]
　QU Li-jie.The Value of Perinatal Comprehensive Nursing Measures and Nutritional Intervention in Gestational Diabetes Patients[J].Medical Information,2018,31(06):171.[doi:10.3969/j.issn.1006-1959.2018.15.057]
[6]刘玉静,朱 静.产后护理管理对妊娠期糖尿病患者血糖控制及疾病认知水平的影响[J].医学信息,2018,31(23):180.[doi:10.3969/j.issn.1006-1959.2018.23.053]
　LIU Yu-jing,ZHU Jing.Effect of Postpartum Nursing Management on Blood Glucose Control and Disease Cognition of Gestational Diabetes Mellitus Patients[J].Medical Information,2018,31(06):180.[doi:10.3969/j.issn.1006-1959.2018.23.053]
[7]于素芳.妊娠期糖尿病的综合干预及药物治疗[J].医学信息,2019,32(01):59.[doi:10.3969/j.issn.1006-1959.2019.01.020]
　YU Su-fang.Comprehensive Intervention and Drug Therapy for Gestational Diabetes Mellitus[J].Medical Information,2019,32(06):59.[doi:10.3969/j.issn.1006-1959.2019.01.020]
[8]吴凌云.临床护理路径在妊娠期糖尿病合并妊娠期高血压患者中的应用[J].医学信息,2019,32(10):181.[doi:10.3969/j.issn.1006-1959.2019.10.061]
　WU Ling-yun.Application of Clinical Nursing Pathway in Gestational Diabetes Mellitus Complicated with Gestational Hypertension[J].Medical Information,2019,32(06):181.[doi:10.3969/j.issn.1006-1959.2019.10.061]
[9]左俊芳,刘沙沙,崔洪艳.妊娠期糖尿病高危因素及预防措施研究[J].医学信息,2022,35(17):177.[doi:10.3969/j.issn.1006-1959.2022.17.048]
　ZUO Jun-fang,LIU Sha-sha,CUI Hong-yan.Study on High Risk Factors and Preventive Measures of Gestational Diabetes Mellitus[J].Medical Information,2022,35(06):177.[doi:10.3969/j.issn.1006-1959.2022.17.048]
[10]王莎莎.孕期膳食指导改善血脂代谢预防妊娠期糖尿病与 妊娠高血压疾病的研究[J].医学信息,2019,32(18):89.[doi:10.3969/j.issn.1006-1959.2019.18.028]
　WANG Sha-sha.Dietary Guidance during Pregnancy Improves Blood Lipid Metabolism to Prevent Gestational Diabetes Mellitus and Pregnancy-induced Hypertension[J].Medical Information,2019,32(06):89.[doi:10.3969/j.issn.1006-1959.2019.18.028]

更新日期/Last Update: 1900-01-01